PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHistiocytosis
MeSH D015614 - histiocytosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008206:Lymphatic diseases
0 Companies
0 Drugs
Success rate
D015614: 
Histiocytosis
$
Success rate
D006646:Langerhans-cell histiocytosis
$
Success rate
D015616:Non-langerhans-cell histiocytosis
0 Companies
0 Drugs
Success rate
D015620:Malignant histiocytic disorders
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Eli LillyVinblastine Velban  1982-01-01   
HospiraVinblastine Vinblastine  1987-08-18   
Hikma PharmaceuticalsVinblastine Vinblastine  1987-04-09   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/1
Phase 3
67%
2/3
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Eli Lilly
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use